The Effects of Unfiltered (Turkish) Coffee Consumption on Cardiovascular Risk Parameters
NCT ID: NCT03495336
Last Updated: 2018-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2017-03-22
2017-10-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: In this crossover intervention study, healthy, nonsmoking, habitual Turkish coffee drinkers (n=28) were randomized to consume at least 3 cups of Light (LR) or Dark (DR) roast Turkish coffee brews per day for 4 weeks after a washout period (WO) of 2 weeks. Subsequent to each coffee abstinence period, both groups received the alternative intervention. After the first WO and the coffee intervention periods, anthropometric measures, blood pressure, heart rate and 13 biochemical parameters were collected and dietary records were completed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects Of Turkish Coffee Consumption On Cardiovascular Markers And Sleep In Healthy Women
NCT07133373
The Effect Of Coffee And Tea Drink On Gis Functions Healing Quality After Surgery in Patients Surgery
NCT06180135
The Effect of Turkish Coffee on Postural Control and Hand-eye Coordination in Young Adults
NCT06561113
The Acute Effect of Coffee Consumption on Stomach, Self-reported Gastrointestinal Symptoms and Stress.
NCT02253628
Health Effects of Coffee Consumption
NCT01759329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Purpose/Objective: The aim of this study is to investigate the impact of boiled unfiltered (Turkish) coffee consumption on the plasma cardiovascular risk parameters of healthy subjects. The study also explores whether two unfiltered boiled (Turkish) coffee beverages that differ in content due to different roasting degrees will differentially affect cardiovascular biomarkers.
Methods: In this crossover intervention study, healthy, nonsmoking, habitual Turkish coffee drinkers (n=28) were randomized to consume at least 3 cups of Light (LR) or Dark (DR) roast Turkish coffee brews per day for 4 weeks after a washout period (WO) of 2 weeks. Subsequent to each coffee abstinence period, both groups received the alternative intervention. After the first WO and the coffee intervention periods, anthropometric measures, blood pressure, heart rate and 13 biochemical parameters were collected and dietary records were completed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Washout period
Coffee abstention phase for 2 weeks.
coffee abstention phase
no coffee consumption for 2 weeks
Light roast coffee (LR)
Participants will follow LR Coffee consumption procedure and consume at least 3 cups of Light (LR) roast Turkish coffee brews per day for 4 weeks after a washout period (WO) of 2 weeks.
LR Coffee consumption
for 4 weeks participants consumed only LR Turkish coffee
Second washout period
coffee abstention phase for 2 weeks
coffee abstention phase
no coffee consumption for 2 weeks
Dark roast coffee (DR)
Participants will follow DR Coffee consumption procedure and consume at least 3 cups of Dark (DR) roast Turkish coffee brews per day for 4 weeks after a washout period (WO) of 2 weeks.
DR Coffee consumption
for 4 weeks participants consumed only DR Turkish coffee
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
coffee abstention phase
no coffee consumption for 2 weeks
LR Coffee consumption
for 4 weeks participants consumed only LR Turkish coffee
DR Coffee consumption
for 4 weeks participants consumed only DR Turkish coffee
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index (BMI) 18.5-24.9 kg/m2 )
* Non-smoker or former smoker (more than a year)
* Willingness to abstain from coffee drinking
* Willingness to consume ≥ 3 cups/day of Turkish coffee
Exclusion Criteria
* Severe illness with in-patient treatment during last 3 months
* Use of regular medication or any supplements
* Weight reduction ˃2 kg/week during the last month
* Pregnancy or breastfeeding
* Regular strong physical activity with ≥1h/day
* High alcohol intake a weekly intake of ˃7 units for women and ˃14units for men
* Excess consumption of total fat ˃35% of daily calories
* Consumption of saturated fatty acid ˃10% of daily calories
* Cholesterol intake ˃300mg/day
20 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eastern Mediterranean University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatma Hülyam Eren
Instructor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tanju Besler, Prof.
Role: STUDY_CHAIR
Eastern Mediterranean University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eastern Mediterrenean University
Famagusta, , Cyprus
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EasternMedU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.